Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2011-08-30
2011-08-30
Bowman, Amy (Department: 1635)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C424S093100
Reexamination Certificate
active
08008009
ABSTRACT:
The present invention concerns a method for in vitro diagnosis of cancer, in particular breast, thyroid or lung cancer, which consists in determining the presence of ProNGF in a biological sample derived from a patient suspected of suffering from cancer, in particular breast, thyroid or lung cancer. Said method may be used for early diagnosis, screening, therapeutic follow-up, prognosis and for diagnosing relapses in cancer and in particular breast, thyroid or lung cancer.The present invention also concerns the use of a ProNGF inhibitor for preparing a drug, said drug being in particular useful for blocking remote dissemination and cell invasion in patients suffering from cancer, in particular breast, thyroid or lung cancer.The invention is applicable in the field of diagnosis and therapeutics.
REFERENCES:
patent: 2001/0046959 (2001-11-01), Buchkovich et al.
patent: 2006/0051818 (2006-03-01), Adriaenssens et al.
patent: WO 03/076942 (2003-09-01), None
patent: WO 2004/040312 (2004-05-01), None
patent: WO 2004/056385 (2004-07-01), None
patent: WO 2005/076695 (2005-08-01), None
Bierl et al., “‘Mature’ nerve growth factor is a minor species in most peripheral tissues,”Neuroscience Letters, vol. 380, pp. 133-137, Jan. 2005.
Hasan et al. “Sympathetic Neurons Synthesize and Secrete Pro-Nerve Growth Factor Protein,”Journal of Neurobiology, vol. 57, pp. 38-53, Apr. 2003.
Mazella et al., “The 100-kDa Neurotensin Receptor Is gp95/Sortilin, A Non-G-Protein-coupled Receptor,”The Journal of Biological Chemistry, vol. 273, No. 41, pp. 26273-26276, Oct. 9, 1998.
Nykjaer et al., “Sortilin is essential for proNGF-induced neuronal cell death,”Nature, vol. 427, pp. 843-848, Feb. 26, 2004.
Pedraza et al., “Pro-NGF Isolated from the Human Brain Affected by Alzheimer's Disease Induces Neuronal Apoptosis Mediated By p75NTR,”American Journal of Pathology, vol. 166, No. 2, pp. 533-543, Feb. 2, 2005.
Descamps et al., “Nerve Growth Factor Is Mitogenic for Cancerous but Not Normal Human Breast Epithelial Cells,”The Journal of Biological Chemistry, vol. 273, No. 27, pp. 16659-16662, Jul. 3, 1998.
Tagliabue et al., “Nerve Growth Factor Cooperates with p185HER2in Activating Growth of Human Breast Carcinoma Cells,”The Journal of Biological Chemistry, vol. 275, No. 8, pp. 5388-5394, Feb. 25, 2000.
Dolle et al., “Nerve growth factor overexpression and autocrine loop in breast cancer cells,”Oncogene, vol. 22, pp. 5592-5601, Aug. 28, 2003.
Fahnestock et al., “The Precursor Pro-Nerve Growth Factor Is the Predominant Form of Nerve Growth Factor in Brain and Is Increased in Alzheimer's Disease,”Molecular and Cellular Neuroscience, vol. 18, No. 2, pp. 210-219, Aug. 2001.
Choquet-Kastylevsky Genevieve
Demont Yohan
Hondermarck Hubert
Biomerieux
Bowman Amy
Oliff & Berridg,e PLC
University des Sciences et Technologies de Lille
LandOfFree
Method for ProNGF assay for in vitro diagnosis of cancer in... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for ProNGF assay for in vitro diagnosis of cancer in..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for ProNGF assay for in vitro diagnosis of cancer in... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2796518